sur Zomedica Corp. (NASDAQ:ZOM)
Zomedica Expands UK Presence with Strategic Distribution Agreement
Zomedica Corp., a veterinary health company, has announced a strategic distribution partnership with Pioneer Veterinary Products Limited to strengthen its market position in the UK. This agreement aims to increase the availability of Zomedica's advanced diagnostic and therapeutic products for animals. Pioneer will distribute the TRUFORMA® diagnostic platform, with VETGuardian® remote monitoring technology expected to follow. This partnership offers exclusive sales support for small animal markets and non-exclusive distribution for equine products across the UK.
The TRUFORMA platform provides lab-quality results at point-of-care, enhancing the diagnosis of endocrine and thyroid conditions in pets. Pioneer anticipates integrating VETGuardian®, which offers wireless, real-time monitoring for animals, improving surgical and post-operative care. Zomedica's CEO, Larry Heaton, views this agreement as a crucial step in expanding their UK footprint and aligning with global market leadership ambitions.
Pioneer's Managing Director, Clive Groombridge, expresses enthusiasm for the collaboration, noting the alignment with their mission to support veterinary professionals. The partnership is set to improve access to advanced veterinary tools, thereby enhancing patient outcomes and practice efficiency in the UK.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Zomedica Corp.